JayendraKPatelMD

PubMed

• 94 citations
  Special Section on CATIE Baseline Data: Baseline Use of Concomitant Psychotropic Medications to Treat Schizophrenia in the CATIE Trial
  Miranda Chakos, Ira D. Glick, Alexander L. Miller, Mark B. Hamner, Del D. Miller, Jayendra K. Patel, Andre Tapp, Richard S.E. Keefe, Robert A. Rosenheck> ;Psychiatric Services. 2006 Aug 1
• Suicidal ideation and depressive symptoms among bipolar patients as predictors of the health and well-being of caregivers.
  Chessick CA, Perlick DA, Miklowitz DJ, Dickinson LM, Allen MH, Morris CD, Gonzalez JM, Marangell LB, Cosgrove V, Ostacher M, STED-BD Family Experience Collaborative St...> ;Bipolar disorders.
• 58 citations
  Antidepressant augmentation using the N-methyl-D-aspartate antagonist memantine: a randomized, double-blind, placebo-controlled trial.
  Eric G. Smith, Kristina M. Deligiannidis, Christine M. Ulbricht, Chelsea S. Landolin, Jayendra K. Patel, Anthony J. Rothschild> ;The Journal of Clinical Psychiatry. 2013 Oct 15
• 87 citations
  Metformin for weight loss and metabolic control in overweight outpatients with schizophrenia and schizoaffective disorder.
  L. Fredrik Jarskog, Robert M. Hamer, Diane J. Catellier, Dawn Stewart, Lisa M. LaVange, Neepa Ray, Lauren H. Golden, Jeffrey A. Lieberman, T. Scott Stroup, Lawrence Ad...> ;The American Journal of Psychiatry. 2013 Sep 1
• 63 citations
  Feasibility and Pilot Efficacy Results From the Multisite Cognitive Remediation in the Schizophrenia Trials Network (CRSTN) Randomized Controlled Trial
  Richard S.E. Keefe, Sophia Vinogradov, Alice Medalia, Peter F. Buckley, Stanley N. Caroff, Deepak Cyril D'Souza, P.D. Harvey, Karen A. Graham, Robert M. Hamer, Stephen...> ;The Journal of Clinical Psychiatry. 2012 May 15
• 43 citations
  Substance use and schizophrenia: adverse correlates in the CATIE study sample.
  Karin E. Kerfoot, Robert A. Rosenheck, Ismene L. Petrakis, Marvin S. Swartz, Richard S.E. Keefe, Joseph P. McEvoy, T. Scott Stroup, Lenard A. Adler, M. Bari, I. Belz, ...> ;Schizophrenia Research. 2011 Nov 1
• A randomized trial examining the effectiveness of switching from olanzapine, quetiapine, or risperidone to aripiprazole to reduce metabolic risk: comparison of antipsy...
  Stroup TS, McEvoy JP, Ring KD, Hamer RH, LaVange LM, Swartz MS, Rosenheck RA, Perkins DO, Nussbaum AM, Lieberman JA, Schizophrenia Trials Network> ;The American journal of psychiatry. 2011-07-18
• 108 citations
  Effectiveness of Switching from Antipsychotic Polypharmacy to Monotherapy
  Susan M. Essock, Nina R. Schooler, T. Scott Stroup, Joseph P. McEvoy, Ingrid A Rojas, Carlos T. Jackson, Nancy H. Covell, Lenard A. Adler, Matthew J. Byerly, Stanley N...> ;The American Journal of Psychiatry. 2011 Jul 1
• 116 citations
  Association study of 21 circadian genes with bipolar I disorder, schizoaffective disorder, and schizophrenia
  Hader Mansour, Michael E. Talkowski, Joel Wood, Kodavali V. Chowdari, Lora McClain, Konasale M. Prasad, Debra M. Montrose, Andrea Fagiolini, Edward S. Friedman, Michae...> ;Bipolar Disorders. 2009 Nov 1
• 111 citations
  Metabolic profiles of second-generation antipsychotics in early psychosis: Findings from the CAFE study
  Jayendra K. Patel, Peter F. Buckley, Sandra Woolson, Robert M. Hamer, Joseph P. McEvoy, Diana O. Perkins, Jeffrey A. Lieberman> ;Schizophrenia Research. 2009 Jun 1
• 11 citations
  Linkage disequilibrium mapping of the chromosome 6q21-22.31 bipolar I disorder susceptibility locus.
  Jinbo Fan, Iuliana Ionita-Laza, Matthew B. McQueen, Bernie Devlin, Shaun Purcell, Stephen V. Faraone, Michael H. Allen, Charles L. Bowden, Joseph R. Calabrese, Mark D....> ;American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics. 2009 Mar 23
• 119 citations
  A placebo-controlled add-on trial of the Ampakine, CX516, for cognitive deficits in schizophrenia.
  Donald C. Goff, J. Steven Lamberti, Andrew C. Leon, Michael F. Green, Alexander L. Miller, Jayendra K. Patel, Theo C. Manschreck, Oliver Freudenreich, Steven A. Johnson> ;Neuropsychopharmacology. 2008 Feb 1
• The effectiveness of antipsychotic medications in patients who use or avoid illicit substances: results from the CATIE study.
  Swartz MS, Wagner HR, Swanson JW, Stroup TS, McEvoy JP, Reimherr F, Miller DD, McGee M, Khan A, Canive JM, Davis SM, Hsiao JK, Lieberman JA, CATIE Investigators> ;Schizophrenia research. 2008-01-11
• 156 citations
  Intensive psychosocial intervention enhances functioning in patients with bipolar depression: results from a 9-month randomized controlled trial.
  David J. Miklowitz, Michael Otto, Ellen Frank, Noreen A. Reilly-Harrington, Jane N. Kogan, Gary S. Sachs, Michael E. Thase, Joseph R. Calabrese, Lauren B. Marangell, M...> ;The American Journal of Psychiatry. 2007 Sep 1
• 98 citations
  Prevalence and correlates of burden among caregivers of patients with bipolar disorder enrolled in the Systematic Treatment Enhancement Program for Bipolar Disorder.
  Deborah A. Perlick, Robert A. Rosenheck, David J. Miklowitz, Cheryl A. Chessick, Nancy Wolff, Richard Kaczynski, Michael J. Ostacher, Jayendra Patel, Rani A. Desai> ;Bipolar Disorders. 2007 May 1
• 574 citations
  Effectiveness of Adjunctive Antidepressant Treatment for Bipolar Depression
  Gary S. Sachs, Andrew A. Nierenberg, Joseph R. Calabrese, Lauren B. Marangell, Stephen R. Wisniewski, Laszlo Gyulai, Edward S. Friedman, Charles L. Bowden, Mark D. Fos...> ;The New England Journal of Medicine. 2007 Apr 26
• 459 citations
  Predictors of recurrence in bipolar disorder: primary outcomes from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).
  Roy H. Perlis, Michael J. Ostacher, Jayendra K. Patel, Lauren B. Marangell, Hongwei Zhang, Stephen R. Wisniewski, Terence A. Ketter, David J. Miklowitz, Michael W. Ott...> ;The American Journal of Psychiatry. 2006 Feb 1
• 147 citations
  The Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Schizophrenia Trial: Clinical comparison of subgroups with and without the metabolic syndrome
  Jonathan M. Meyer, Henry A. Nasrallah, Joseph P. McEvoy, Donald C. Goff, Sonia M. Davis, Miranda Chakos, Jayendra K. Patel, Richard S.E. Keefe, T. Scott Stroup, Jeffre...> ;Schizophrenia Research. 2005 Dec 1
• 19 citations
  Quality of life during treatment with haloperidol or olanzapine in the year following a first psychotic episode.
  Stephen M. Strakowski, Jacqueline L. Johnson, Melissa P. DelBello, Robert M. Hamer, Alan I. Green, Mauricio Tohen, Jeffrey A. Lieberman, Ira D. Glick, Jayendra K. Pate...> ;Schizophrenia Research. 2005 Oct 15
• 11 citations
  Clozapine action on auditory P3 response in schizophrenia.
  Margaret A. Niznikiewicz, Jayendra K. Patel, Robert W. McCarley, Jonathan Sutton, David T. Chau, Joanne Wojcik, Alan I. Green> ;Schizophrenia Research. 2005 Jul 1
• 31 citations
  Serotonin gene polymorphisms and bipolar I disorder: focus on the serotonin transporter.
  Hader Mansour, Michael E. Talkowski, Joel Wood, L Pless, Mikhil Bamne, Kodavali V. Chowdari, Michael H. Allen, Charles L. Bowden, Joseph R. Calabrese, Rif S. El-Mallak...> ;Annals of Medicine. 2005 Jan 1
• 42 citations
  Sudden cardiac death and antipsychotic drugs: do we know enough?
  Carlos A. Zarate, Jayendra K. Patel> ;Archives of General Psychiatry. 2001 Dec 1
• 82 citations
  Clozapine in the Treatment of Refractory Psychotic Mania
  Alan I. Green, Maricio Tohen, Jayendra K. Patel, Michael D. Banov, Curtiss J. DuRand, Ileana Berman, Howard H Chang, Carlos A. Zarate, Joel A. Posener, Hang Lee, Ree D...> ;The American Journal of Psychiatry. 2000 Jun 1
• 19 citations
  Clozapine and Paroxetine in the Treatment of Schizophrenia With Obsessive-Compulsive Features
  Rael D. Strous, Jayendra K. Patel, Suzanna V. Zimmet, Alan I. Green> ;The American Journal of Psychiatry. 1999 Jun 1
• 24 citations
  Olanzapine: A New Antipsychotic Agent with Efficacy in the Management of Schizophrenia
  Judith C Kando, John C Shepski, Winston Satterlee, Jayendra K. Patel, Stephen G Reams, Alan I. Green> ;The Annals of Pharmacotherapy. 1997 Nov 1
• Join now to see all